Nanjing Frontier Acquires Rights to Rockefeller University HIV/AIDS Antibody Jul 25, 2017 Life Science
DelMar Pharmaceuticals Receives Approval from China’s Human Genetic Resources Administration to Initiate Phase 2 Clinical Trial in Newly Diagnosed GBM Jul 25, 2017 Life Science
VolitionRx Limited to host a conference call regarding a 13,500 Subject Colorectal Cancer Screening Trial with the Early Detection Research Network of the U.S. National Cancer Institute Jul 20, 2017 Life Science
RedHill Biopharma Announces Last Patient Visit in BEKINDA® Phase II Study for IBS-D Jul 19, 2017 Life Science
DelMar Pharmaceuticals Announces Completion of First Site Initiation Visit for STAR-3 Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM Jul 19, 2017 Life Science
Lexaria Bioscience Awarded Australian Patent For Cannabinoid Infused Edibles Jul 19, 2017 Life Science
Naturally Splendid Enterprises to Acquire 100% of Privately Owned Innovative Natural Food Company – Video News Alert on Investmentpitch.com Jul 15, 2017 Life Science
RedHill Biopharma Announces Expected Timeline for DSMB meeting and Provides Update on Enrollment in the RHB-104 Phase III Study for Crohn’s Disease Jul 13, 2017 Life Science
Naturally Splendid Enters into Letter of Intent to Acquire Innovative Natural Food Company and Announces Private Placement Financing Jul 13, 2017 Life Science
DelMar Pharmaceuticals Appoints Saiid Zarrabian to the Board of Directors and Names Dr. Erich Mohr as Chairman Jul 12, 2017 Life Science
